SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
SEC Accession No. 0001047469-02-008401
Filing Date
2002-12-26
Accepted
2002-12-26 17:11:14
Documents
5

Document Format Files

Seq Description Document Type Size
1 SC TO-T/A a2097194zscto-ta.htm SC TO-T/A 28823
3 EXHIBIT 99(A)(9) a2097194zex-99_a9.htm EX-99.(A)(9) 5374
5 G326482.JPG g326482.jpg GRAPHIC 5387
6 G570829.JPG g570829.jpg GRAPHIC 9277
7 G199415.JPG g199415.jpg GRAPHIC 3853
  Complete submission text file 0001047469-02-008401.txt   55100
Mailing Address
Business Address 333 LAKESIDE DR FOSTER CITY CA 94404 6505743000
GILEAD SCIENCES INC (Filed by) CIK: 0000882095 (see all company filings)

IRS No.: 943047598 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 4611 UNIVERSITY DRIVE DURHAM NC 27707
Business Address 4611 UNIVERSITY DRIVE DURHAM NC 27707 9194935980
TRIANGLE PHARMACEUTICALS INC (Subject) CIK: 0001022622 (see all company filings)

IRS No.: 561930728 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-T/A | Act: 34 | File No.: 005-47359 | Film No.: 02869308
SIC: 2834 Pharmaceutical Preparations